Top Story

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015

Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently released commentary in the Annals of Internal Medicine.

“As a prescriber, I have been willing to give up my freedom to prescribe any chemical I choose to patients, and I am willing to have drug manufacturers give up some of their right to tell me whatever they may want me to hear. For all of us (including patients) to hand over some liberties to a Hobbesian Sovereign, such as the FDA, offers a different kind of freedom — knowing that the medications we use are probably, at least as a first approximation, reasonably safe and have some evidence that they work,” Jerry Avorn, MD, Harvard School of Medicine, wrote in his paper.

Lori C. Jordan, MD, PhD In the Journals

ED rapid response plan helps diagnose pediatric stroke symptoms

July 2, 2015
Among children presenting to the ED of a single center with brain attacks when a pediatric acute stroke protocol was activated, 40% had a stroke or other neurological…
In the Journals

CHD linked to osteoporosis in older adults

July 2, 2015
Older adults with a history of coronary heart disease have a substantially lower cortical volumetric bone mineral density at the distal radius, putting them at risk for…
Xavier PiSunyer In the Journals

Saxenda linked to reduced body weight, improved metabolic control

July 2, 2015
Reduced body weight and improved metabolic control were found with once-daily subcutaneous Saxenda as an add-on to diet and exercise, according to recent study findings…

ABIM to eliminate underlying certification requirement for nine subspecialties

July 2, 2015
The American Board of Internal Medicine announced that it will eliminate the requirement that diplomates certified in specifically designated subspecialties also have to…
More News Headlines »
CME
Cardiology Case Consults

The Patient with Acute Coronary Syndrome

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute coronary syndrome.
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Platelet Function and Genetic Testing Current Status and Use

Platelet Function and Genetic Testing: Current Status and Use

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
morganatic-roan
morganatic-roan